Marion Dode (Donnier-Maréchal) is a senior scientist at Illumina, having previously served as a scientist and senior scientist focusing on product development and analytical sciences. Marion obtained a PhD in organic chemistry from Université de Lille 2, where they developed novel sigma-1 receptor agonists aimed at treating neurodegenerative diseases, resulting in several publications and a patent. Marion's extensive research experience includes postdoctoral roles at the University of Cambridge and Université Claude Bernard Lyon 1, as well as a master's research position at Trinity College Dublin. They have contributed significantly to organic synthesis and molecular imaging applications throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices